Risk-factors and multimorbidity in oral anticoagulant-related intracerebral haemorrhage: a comparison of patients in pivotal trials and real life

In conclusion, burden of risk-factors and comorbidities were similar in real-life patients with DOAC-ICH and VKA-ICH, as well as in real-life patients compared to trial-life patients. However, real-life patients especially those on DOAC, were older and more frequently women than trial-life patients. It is reassuring that burden of comorbidity was similar in real-life and trial-life patients. Nevertheless, this report underlines the importance of recruiting adequate numbers of older people and women to cardio-vascular trials to ensure sufficient safety data to advice prescriptions in these very prevalent sub-groups of patients.

Authors

Institutions

Publication Details

Journal
Age and Ageing
Published
2025-03-28
DOI
https://doi.org/10.1093/ageing/afaf091
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk-factors and multimorbidity in oral anticoagulant-related intracerebral haemorrhage: a comparison of patients in pivotal trials and real life

Karen Ægidius, Jacob Marstrand, Christina Kruuse, Thomas Christensen et al.
Age and Ageing
Atrial Fibrillation Management and Outcomes
article

Risk-factors and multimorbidity in oral anticoagulant-related intracerebral haemorrhage: a comparison of patients in pivotal trials and real life

Karen Ægidius, Jacob Marstrand, Christina Kruuse, Thomas Christensen, Hanne Christensen, David Gaist, Inger Havsteen, Alexander Lilja‐Cyron, Helle Klingenberg Iversen, Sverre Rosenbaum, Thorsten Steiner, Per Meden, Christian Ovesen, Josefine Grundtvig, Louisa Christensen
article en

Abstract

In conclusion, burden of risk-factors and comorbidities were similar in real-life patients with DOAC-ICH and VKA-ICH, as well as in real-life patients compared to trial-life patients. However, real-life patients especially those on DOAC, were older and more frequently women than trial-life patients. It is reassuring that burden of comorbidity was similar in real-life and trial-life patients. Nevertheless, this report underlines the importance of recruiting adequate numbers of older people and women to cardio-vascular trials to ensure sufficient safety data to advice prescriptions in these very prevalent sub-groups of patients.

Age and AgeingVol. 54(4)
Heidelberg University (DE), Odense University Hospital (DK), Bispebjerg Hospital (DK), University Hospital Heidelberg (DE), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), Region of Southern Denmark (DK), Klinikum Frankfurt Höchst (DE)
Lundbeckfonden
Good health and well-being
Openalex Percentile: Top 87%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.